Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
about
Regulation of immune cell function and differentiation by the NKG2D receptorRecognition and killing of cancer stem-like cell population in hepatocellular carcinoma cells by cytokine-induced killer cells via NKG2d-ligands recognitionNKG2D Ligands in Tumor Immunity: Two Sides of a CoinCD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumorsComplexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition SystemsA truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function.Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cureMeasuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay.Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantationNKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCTAntitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancerIncreased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review.The Myeloid LSECtin Is a DAP12-Coupled Receptor That Is Crucial for Inflammatory Response Induced by Ebola Virus Glycoprotein.Potential immunosuppressive effects of Escherichia coli O157:H7 experimental infection on the bovine host.The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation.MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells.Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion.Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognitionCytokine-induced killer cells promote antitumor immunityCytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literatureIn vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activityTranscriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg ResponseIntratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival.Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies.Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.A killer choice for cancer immunotherapy.The use of microRNA by human viruses: lessons from NK cells and HCMV infection.Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.Cancer Immunotherapy with Cytokine-Induced Killer Cells.The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells.Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathwayDifferential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.Inhibition of human ovarian tumor growth by cytokine-induced killer cells.A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma.Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer.A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role.Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature reviewSoluble NKG2D ligand promotes MDSC expansion and skews macrophage to the alternatively activated phenotype.Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria.
P2860
Q24635093-856098E3-59E9-41E4-93A6-7ABF7563B134Q27311035-11B38FC8-6395-418F-8596-0E93902DFB67Q28083832-651FB6C5-210D-41B0-AF21-9AB20AA77AB0Q30442426-02031F2F-0AA2-4B7B-8C28-D48A52835621Q33696425-BE5AD8A3-1982-438F-BE28-2B27F6D2221AQ34146619-B6DDD390-30DA-4C11-9BB1-A88C558BF80AQ34905582-EDFFD454-0C57-4984-AEEC-1265692C8B5BQ35107127-FBD1DC56-4EF4-4EC0-805B-BC65E76D1C3EQ35218943-6C80744B-11CD-48E7-9A87-3F2A494DB743Q35692428-51273892-854B-49E0-9120-C1C9024D67CFQ35817271-5882E99C-DD1E-4FB6-B945-0B2A34187EB2Q35870544-8A2CD84E-0D74-4E5B-85DB-2DB83E5AED1DQ35946272-B9CC897D-8047-462B-9205-A0290A071B6CQ36230692-9B4B5080-F0FD-45D9-B3D0-E75572B74A1CQ36278732-02D9D412-94FC-416D-84F6-B7E9DD83A7E8Q36309435-8865F7C5-D1F3-4C98-BC57-2975D45BA207Q36351988-2072B9D1-007E-46AF-B562-C2C0F4CD1534Q36544290-46B5415F-21CC-4066-8AEF-6B75D803BAABQ36741617-AAA71F43-BA99-4369-A8EF-603DD96FD8D7Q36774574-BF92A173-CD02-44CD-AAC5-6360652306B0Q36868792-20040359-3AD4-45B9-93B1-32BAD450778AQ36993318-80758D16-196C-4707-8EB9-CB6328C98FACQ37038652-4ECCEE8F-3C13-4785-9305-43ED0C533858Q37224604-FE4AC5A7-79DC-4624-9C57-E2A359E48286Q38002494-BCD03599-CB38-4E84-AD25-D36F7F2B99D3Q38208944-9C36C065-CC5E-4193-8A94-31AFEF75CE2FQ38252422-C81DD1A0-24E4-4C75-8897-8A747A7CD9BAQ38574526-74312439-BD8C-4962-96D5-9784462E46FEQ38687547-4080E4D0-7D54-4031-A6CD-30B38FA823DDQ39032449-EE445B22-89FB-4231-883D-2058DEED9906Q39317127-AF36AB4C-8283-451D-9B72-E1E28D7822D4Q39332073-0C961658-86BD-45A5-AB99-384FFC6FE9E4Q39828959-5895786A-AF54-45E8-B255-3460D96E698DQ40034102-14F0FF06-99C3-428C-9353-D4AEE6755DC7Q40224948-7BEB6005-C8DE-4CBD-98E5-3808D99B27F7Q41097111-5BEC812F-D5C8-42A0-A3A9-2E9EC7B42653Q42079725-1F075BAE-0B44-4B25-961C-D5FA033E78DCQ42283208-9BAE6972-914E-4DA3-A807-94EA7260D05AQ42962555-C72415F0-0FFD-4E2F-A427-BAB5292D02AAQ43725629-5A297192-4278-4BAE-A6D2-B996898B1100
P2860
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@ast
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@en
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@nl
type
label
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@ast
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@en
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@nl
prefLabel
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@ast
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@en
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@nl
P2093
P1476
Silencing human NKG2D, DAP10, ...... ted CD8+ T cells and NK cells.
@en
P2093
Jeanette A Baker
Luis Soares
Michael R Verneris
Mobin Karimi
Robert S Negrin
Thai M Cao
P304
P356
10.4049/JIMMUNOL.175.12.7819
P407
P577
2005-12-01T00:00:00Z